Superhero Fatigue Is Real — And Indie Filmmakers Are Finally Seeing the Cracks in the Wall

There's a scene that plays out in Hollywood development meetings that almost never makes the trades. A filmmaker pitches a mid-budget drama — smart script, grounded characters, maybe $30 million to make it right. The executive across the table nods politely, maybe even says they love it. Then comes the question that kills it dead: But where's the franchise potential?

For the better part of fifteen years, that question has functioned less like a creative prompt and more like a trap door. If your story doesn't have a universe attached to it, a sequel roadmap baked in, or a pre-existing IP to hang it on, you're not getting a multiplex release. You might get a streaming dump. You might get nothing at all.

That's the world Marvel and DC built — and the rest of Hollywood enthusiastically moved into.

How the Multiplex Got Colonized

The numbers tell a pretty blunt story. Between 2012 and 2022, Marvel Studios alone released 23 films that grossed over $800 million globally on average. DC, despite a bumpier ride creatively, still managed to dominate release calendars and command the kinds of screen counts that smaller films could only dream about. At peak franchise saturation, a single MCU film could open on 4,500-plus screens in North America. That's not just market share — that's market occupation.

The downstream effect on mid-budget original filmmaking was brutal. Studios that once greenlit $20-50 million character studies, thrillers, and adult dramas — the kinds of films that defined the 1970s and '90s golden eras — essentially stopped making them for theatrical. The math wasn't complicated: why take a risk on an original IP when you could pour resources into something with built-in audience awareness and merchandise revenue?

The casualties weren't just box office stats. They were careers. An entire tier of working filmmaker — the kind who might have directed a sharp crime drama or a wrenching family saga with a modest budget and walked away with a hit — found themselves either chasing franchise work or retreating to streaming and prestige TV.

"The middle of the market didn't just shrink," one veteran producer told a film industry panel last year. "It basically ceased to exist in theaters."

The Stumbles Nobody Saw Coming (Or Did They?)

Here's where the story gets interesting. Starting around 2022 and accelerating hard through 2023 and 2024, the franchise machine started misfiring in ways the studios couldn't easily explain away.

Ant-Man and the Wasp: Quantumania — meant to launch a new MCU phase with Kang the Conqueror as the next Thanos-level threat — opened to disappointing numbers and faded fast. The Marvels became one of the lowest-grossing MCU films ever, pulling in barely $200 million worldwide against a reported $220 million production budget. DC's attempts to reboot and recalibrate under James Gunn produced mixed results, with Joker: Folie à Deux landing as one of the most high-profile box office disasters in recent memory despite the original film's massive success.

These weren't flukes. They were signals.

Audiences, it turns out, aren't infinitely elastic. Superhero fatigue — a concept the studios spent years insisting was a myth — showed up in the data with uncomfortable clarity. Casual moviegoers, the ones who used to show up for Avengers out of cultural obligation, started staying home. The hardcore fans remained, but they weren't enough to carry $200 million productions into profit.

What the Greenlight Numbers Actually Show

Perhaps more revealing than box office performance is what's happening at the development stage. Industry tracking from the past 18 months shows a quiet but real shift in how studios are approaching their slates. Universal, which never went all-in on the superhero model the way Disney and Warner Bros. did, has been rewarded for its relative restraint — films like Oppenheimer and M3GAN demonstrated that original or modestly IP-adjacent projects could still move serious numbers when marketed correctly.

A24, Neon, and other specialty distributors have continued to find theatrical audiences for films that would have been written off as streaming-only content five years ago. Past Lives, All of Us Strangers, The Zone of Interest — none of these are franchise material, and all of them found real audiences in theaters.

More tellingly, some of the major studios have started quietly dusting off development deals for original screenplays that had been sitting in turnaround for years. It's not a flood. But it's a trickle that filmmakers working in the mid-budget space are paying very close attention to.

The 2025 Question: Correction or Pause?

So is this a genuine market correction, or are we watching the studios catch their breath before loading up the next phase of franchise content?

Honestly, it's probably some of both — and that ambiguity is worth sitting with rather than resolving too quickly.

On one hand, the structural incentives that created franchise dominance haven't disappeared. Disney still controls Marvel. Warner Bros. Discovery is still deeply invested in DC's theatrical future under Gunn. These aren't companies that abandon $10 billion franchises because of a rough two-year stretch. The next Avengers film, Doomsday, is already generating significant pre-release buzz, and if it performs, expect the studios to declare the correction over and double down hard.

On the other hand, something has genuinely shifted in how audiences talk about these films. The cultural conversation around superhero movies has changed tone. They're no longer the default prestige event; they're just another option. That's a meaningful psychological shift, and it creates at least some breathing room for other kinds of stories.

For independent filmmakers and mid-budget directors, the opportunity window — if it exists — is narrow and probably temporary. The smart play is to move fast, make compelling cases to distributors who are actively looking for alternatives to franchise dependency, and deliver films that remind audiences why they fell in love with movies in the first place.

The Filmmakers Waiting in the Wings

There's no shortage of talent ready to fill that space. Directors who spent the last decade building credits in streaming originals, prestige television, and festival circuits have developed real craft and real audiences. They have stories to tell that don't require post-credits scenes or interconnected universe planning.

What they need is screen time. They need studios and distributors willing to bet that a well-made, well-marketed original film can still compete for attention in a multiplex environment. The evidence, however modest, suggests that bet isn't crazy.

The franchise stranglehold on American moviegoing didn't happen overnight, and it won't loosen overnight either. But the cracks are visible now in ways they simply weren't three years ago. Whether the industry is bold enough to widen them — or whether the next phase of Marvel content papers over them before anyone can — is the defining question for theatrical filmmaking heading into the back half of this decade.

Film culture has always been resilient. It scratches back. The question is whether the business around it is finally ready to let it.